Correlation Between Pliant Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Pliant Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Pliant Therapeutics and Aerovate Therapeutics
0.8 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pliant and Aerovate is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Aerovate Therapeutics. In addition to that, Pliant Therapeutics is 10.6 times more volatile than Aerovate Therapeutics. It trades about -0.21 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.19 per unit of volatility. If you would invest 258.00 in Aerovate Therapeutics on November 30, 2024 and sell it today you would lose (16.00) from holding Aerovate Therapeutics or give up 6.2% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Pliant Therapeutics vs. Aerovate Therapeutics
Performance |
Timeline |
Pliant Therapeutics |
Aerovate Therapeutics |
Pliant Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pliant Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Pliant Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.Pliant Therapeutics vs. Relay Therapeutics | ||
Pliant Therapeutics vs. Stoke Therapeutics | ||
Pliant Therapeutics vs. Black Diamond Therapeutics | ||
Pliant Therapeutics vs. Arvinas |
Aerovate Therapeutics vs. Adagene | ||
Aerovate Therapeutics vs. Acrivon Therapeutics, Common | ||
Aerovate Therapeutics vs. Rezolute | ||
Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |